Seeking Alpha

Deep.Blue

Deep.Blue
Send Message
View as an RSS Feed
View Deep.Blue's Comments BY TICKER:
Latest  |  Highest rated
  • Amarin's Naysayers: Much Ado About Nothing [View article]
    feuerstein

    under fda guidelines, if fda were to "change their mind" on the spa, they would have to notify amarin in writing that they are "changing their minds". you know this feuerstein, but you continue to misinform people with your innnuendos with nothing to back them up. this is what you do feuerstein. this is what you do.
    Jun 24, 2013. 03:24 PM | 8 Likes Like |Link to Comment
  • Amarin's Naysayers: Much Ado About Nothing [View article]
    feuerstein

    amazing how you consistently proactively and immediately nay say anything that is long biased and sounds intelligent on armn and you do so with no facts. amazing feuerstein.
    Jun 24, 2013. 11:56 AM | 5 Likes Like |Link to Comment
  • Amarin's Naysayers: Much Ado About Nothing [View article]
    feuerstein
    you need to state your case, using fda procedure and protocol, backed up by precedent examples as why you think the agreed upon spa is not enough. you just pull statements out of a place where the sun doesnt shine and thats all you do. that is all you do feuerstein
    Jun 24, 2013. 11:40 AM | 7 Likes Like |Link to Comment
  • Amarin Is Dead With Or Without ANCHOR [View article]
    Kid

    6/15 Script data is out. Scripts up another 6.44% week/week.

    Update your analysis kid.
    Jun 21, 2013. 05:13 PM | 1 Like Like |Link to Comment
  • Amarin's Anchor Will Hold As Vascepa's Sails Unfurl [View article]
    Thanks for bringing some sanity to the coverage of AMRN.
    Jun 21, 2013. 11:12 AM | 3 Likes Like |Link to Comment
  • GTX Inc.: The Company's Next Moves [View article]
    Thanks for writing the article Cora. Nice work.
    Jun 17, 2013. 10:02 AM | 1 Like Like |Link to Comment
  • Amarin: Mr. NCE Guy Has Left The Building [View article]
    Short more kid. Did you now that over the last two weeks scripts are growing 8 pct a week and if you actually look at the numbers closely, there weren't a lot of refills this past week, likely due to under reporting variances.

    Vascepa on track for $100mm in sales this year BASED ONLY ON MARINE AND WITH AN INSANELY PUNY SALESFORCE.

    SHORT MORE KID!
    Jun 16, 2013. 09:57 PM | 9 Likes Like |Link to Comment
  • Amarin Investors Should Avoid The Bullish Speculation [View article]
    Kid, do your cash flow analysis. You are as bad as that guy that writes for the street.com. running from one story to another.
    Jun 12, 2013. 10:29 AM | 3 Likes Like |Link to Comment
  • Bull, Bear, Or Indifferent: Profiting From Amarin's Latest [View article]
    And what about script growth? Vascepa has a been a steady launch since January with its tiny salesforce... What would big pharma do with a much bigger sales force?
    Jun 11, 2013. 09:44 AM | Likes Like |Link to Comment
  • Amarin Investors Should Avoid The Bear Traps [View article]
    Quoth, you still owe us your cash flow analysis kid! Hilarious!
    Jun 10, 2013. 04:34 PM | 3 Likes Like |Link to Comment
  • Amarin Investors Should Avoid The Bear Traps [View article]
    feuerstein -

    that was no answer to my questions. just more smoke and mirrors and maneuevering.

    so again, why do you move from one short thesis to another whenever your thesis doesnt play out? why cant you take ownership of your theses when they dont play out? why?

    this is what you do feuerstein!!!!!!!!
    Jun 10, 2013. 02:17 PM | 3 Likes Like |Link to Comment
  • Amarin Investors Should Avoid The Bear Traps [View article]
    feuerstein

    all you do is move from one short argument to another, never taking responsibility. first you say Vascepa wont launch on time, having zero analysis or research to back it up. when that doesnt work, you just let go of that thesis, acknowledging nothing and now you say that fda will require the outcomes study to be completed, again with nothing backing up your thesis.

    this what you do feuerstein!
    Jun 10, 2013. 11:26 AM | 8 Likes Like |Link to Comment
  • Kudos To Adam Feurstein, For Once... [View instapost]
    Steve

    What do you think of the royalty deal as a strategic approach - if ELN warchests up the company to hire a big salesforce for Anchor and then reaps a royalty. Mgt has laid the groundwork w the Marine lauch already and would have the funds to get the word out. Does this make sense? Feels like the trade off would be stock price that could over the long run go to the moon balanced against increased short term launch risk...
    May 30, 2013. 04:58 PM | Likes Like |Link to Comment
  • Dare I Say Amarin Looks Bullish On Good News? [View article]
    when are you going to do your cash flow analysis?
    May 30, 2013. 04:35 PM | 1 Like Like |Link to Comment
  • Dare I Say Amarin Looks Bullish On Good News? [View article]
    i think people have done the cash flow analysis and realized its not a short.
    May 30, 2013. 12:16 PM | Likes Like |Link to Comment
COMMENTS STATS
131 Comments
202 Likes